The Left Atrial Appendage Closure Device (LAACD) is a medical device used to reduce the risk of stroke in patients with atrial fibrillation. It is a minimally invasive procedure that involves the placement of a device in the left atrial appendage, a small pouch in the heart, to prevent blood clots from forming and entering the bloodstream. The device is designed to reduce the risk of stroke without the need for long-term anticoagulation therapy. The LAACD market is a rapidly growing segment of the cardiovascular device market. It is estimated that the LAACD market will continue to grow due to the increasing prevalence of atrial fibrillation and the need for stroke prevention. The market is expected to benefit from technological advancements, such as the development of new devices and improved delivery systems. Some of the major players in the LAACD market include Abbott, Boston Scientific, Medtronic, and St. Jude Medical. These companies are actively developing and marketing LAACD devices to meet the needs of patients with atrial fibrillation. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
